Tech Company Financing Transactions

AltruBio Funding Round

On 5/21/2024, AltruBio secured $225 million in Series B funding from BVF Partners, aMoon Fund and Blackstone.

Transaction Overview

Company Name
Announced On
5/21/2024
Transaction Type
Venture Equity
Amount
$225,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance the clinical development of its immune checkpoint enhancer (ICE) PSGL-1 agonist antibody, ALTB-268, and to support ongoing and planned Phase 2 clinical trials in ulcerative colitis (UC).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Twin Dolphin Dr. 310
Redwood City, CA 94065
USA
Email Address
Overview
AltruBio is developing first-in-class immune-modulators to target diseases of the immune system. Its world-class global team brings a breadth of expertise in immunology and drug development to bring their biologic treatments to patients. AltruBio has clinically validated a first-in-class immune checkpoint regulator to selectively target unwanted T-cells.
Profile
AltruBio LinkedIn Company Profile
Social Media
AltruBio Company Twitter Account
Company News
AltruBio News
Facebook
AltruBio on Facebook
YouTube
AltruBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Judy Chou
  Judy Chou LinkedIn Profile  Judy Chou Twitter Account  Judy Chou News  Judy Chou on Facebook
President
Shih-Yao Lin
  Shih-Yao Lin LinkedIn Profile  Shih-Yao Lin Twitter Account  Shih-Yao Lin News  Shih-Yao Lin on Facebook
VP - Administration
Leewen Lin
  Leewen Lin LinkedIn Profile  Leewen Lin Twitter Account  Leewen Lin News  Leewen Lin on Facebook
VP - Bus. Development
Joseph McCracken
  Joseph McCracken LinkedIn Profile  Joseph McCracken Twitter Account  Joseph McCracken News  Joseph McCracken on Facebook
VP - Human Resources
Steve Flint
  Steve Flint LinkedIn Profile  Steve Flint Twitter Account  Steve Flint News  Steve Flint on Facebook
VP - Operations
Simona Reed
  Simona Reed LinkedIn Profile  Simona Reed Twitter Account  Simona Reed News  Simona Reed on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/21/2024: Circtec venture capital transaction
Next: 5/21/2024: Cellugy venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary